What's New?
Pharmaceutical Promotion: UMAO & related laws and regulations
To ensure members have a thorough understanding of the relevant laws, regulations and Codes regarding medicinal material communicating to the...
Tackling the Threat of Antimicrobial Resistance
The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional...
Sharing Session: Potential collaborations with DHCs and Community Pharmacies
To help HKAPI members understand more about the operation of DHC and opportunities for the pharmaceutical industry, the Public-Private Partnership...
Resources
Code of Practice
One Platform Directory
Position Papers
issues
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
|
26
|
27
|
29
|
1
|
2
|
||
|
3
|
4
|
5
|
6
|
8
|
9
|
|
|
10
|
12
|
13
|
15
|
16
|
||
|
17
|
18
|
19
|
20
|
22
|
23
|
|
|
24
|
25
|
26
|
27
|
29
|
30
|
|
|
31
|
1
|
2
|
3
|
5
|
6
|
|
Medical Representatives’ Training Programme 2022
CEO Meeting 2022
Medical Representatives’ Training Programme 2022
Medical Representatives’ Training Programme 2022
Medical Representatives’ Training Programme 2022
Upcoming Events
About HKAPI
To drive the expedient access to innovative healthcare solutions for the people of Hong Kong and Macau with high ethical standards.
Formed in 1968, The Hong Kong Association of the Pharmaceutical Industry has 33 full members, including the world’s top 20 companies engaged in the research and development of pharmaceuticals. Our member companies provide over 70 per cent of the prescription medicines in Hong Kong.
Please fill in the following information for further inquiries.
Address : Room 906-7, 9/F., K. Wah Centre, 191 Java Road, North Point, Hong Kong
Tel : 2528-3061
Fax : 2865-6283
